CONTINUUS PHARMACEUTICALS

Lobbying Spend

—

Filings

Firms Hired

Active Period

2020–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	2	1
2023	—	2	1
2022	—	4	1
2021	—	4	1
2020	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
ML STRATEGIES, LLC	—	13
CAPITOL COUNSEL LLC	—	5

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	15
SENATE	15
Health & Human Services, Dept of (HHS)	4
Office of the Vice President of the United States	2
Defense, Dept of (DOD)	1
White House Office	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	17
Defense	Defense	13
Manufacturing	Manufacturing	4
Economics/Economic Development	Economics/Economic Development	1
Medicare/Medicaid	Medicare/Medicaid	1

CONTINUUS PHARMACEUTICALS — Lobbying Disclosure | Poliscope